INTRODUCTION AND HYPOTHESIS: The objective of this study was to create a valid, reliable, and responsive sexual function measure in women with pelvic floor disorders (PFDs) for both sexually active (SA) and inactive (NSA) women. METHODS: Expert review identified concept gaps and generated items evaluated with cognitive interviews. Women underwent Pelvic Organ Prolapse Quantification (POPQ) exams and completed the Incontinence Severity Index (ISI), a prolapse question from the Epidemiology of Prolapse and Incontinence Questionnaire (ISI scores), the Pelvic Floor Distress Inventory-20 (PFDI-20), and the Female Sexual Function Index (FSFI). Principle components and orthogonal varimax rotation and principle factor analysis with oblique rotation identified item grouping. Cronbach's alpha measured internal consistency. Factor correlations evaluated criterion validation. Change scores compared to change scores in other measures evaluated responsiveness among women who underwent surgery. RESULTS: A total of 589 women gave baseline data, 200 returned surveys after treatment, and 147 provided test-retest data. For SA women, 3 subscales each in 2 domains (21 items) and for NSA women 2 subscales in each of 2 domains (12 items) emerged with robust psychometric properties. Cronbach's alpha ranged from .63 to .91. For SA women, correlations were in the anticipated direction with PFDI-20, ISI, and FSFI scores, POPQ, and EPIQ question #35 (all p < .05). PFDI-20, ISI, and FSFI subscale change scores correlated with Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire International Urogynecological Association-revised (PISQ-IR) factor change scores and with mean change scores in women who underwent surgery (all p < .05). For NSA women, PISQ-IR scores correlated with PFDI-20, ISI scores, and with EPIQ question #35 (all p < .05). No items demonstrated differences between test and retest (all p ≥ .05), indicating stability over time. CONCLUSIONS: The PISQ-IR is a valid, reliable, and responsive measure of sexual function.
INTRODUCTION AND HYPOTHESIS: The objective of this study was to create a valid, reliable, and responsive sexual function measure in women with pelvic floor disorders (PFDs) for both sexually active (SA) and inactive (NSA) women. METHODS: Expert review identified concept gaps and generated items evaluated with cognitive interviews. Women underwent Pelvic Organ Prolapse Quantification (POPQ) exams and completed the Incontinence Severity Index (ISI), a prolapse question from the Epidemiology of Prolapse and Incontinence Questionnaire (ISI scores), the Pelvic Floor Distress Inventory-20 (PFDI-20), and the Female Sexual Function Index (FSFI). Principle components and orthogonal varimax rotation and principle factor analysis with oblique rotation identified item grouping. Cronbach's alpha measured internal consistency. Factor correlations evaluated criterion validation. Change scores compared to change scores in other measures evaluated responsiveness among women who underwent surgery. RESULTS: A total of 589 women gave baseline data, 200 returned surveys after treatment, and 147 provided test-retest data. For SA women, 3 subscales each in 2 domains (21 items) and for NSA women 2 subscales in each of 2 domains (12 items) emerged with robust psychometric properties. Cronbach's alpha ranged from .63 to .91. For SA women, correlations were in the anticipated direction with PFDI-20, ISI, and FSFI scores, POPQ, and EPIQ question #35 (all p < .05). PFDI-20, ISI, and FSFI subscale change scores correlated with Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire International Urogynecological Association-revised (PISQ-IR) factor change scores and with mean change scores in women who underwent surgery (all p < .05). For NSA women, PISQ-IR scores correlated with PFDI-20, ISI scores, and with EPIQ question #35 (all p < .05). No items demonstrated differences between test and retest (all p ≥ .05), indicating stability over time. CONCLUSIONS: The PISQ-IR is a valid, reliable, and responsive measure of sexual function.
Authors: R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith Journal: Am J Obstet Gynecol Date: 1996-07 Impact factor: 8.661
Authors: Todd H Rockwood; Melissa L Constantine; Olusola Adegoke; Rebecca G Rogers; Elektra McDermott; G Willy Davila; Claudine Domoney; Swati Jha; Dorothy Kammerer-Doak; Emily S Lukacz; Mitesh Parekh; Rachel Pauls; Joan Pitkin; Fiona Reid; Beri Ridgeway; Ranee Thakar; Peter K Sand; Suzette E Sutherland; Montserrat Espuna-Pons Journal: Int Urogynecol J Date: 2013-04-30 Impact factor: 2.894
Authors: Rachel N Pauls; Jeffrey L Segal; W Andre Silva; Steven D Kleeman; Mickey M Karram Journal: Int Urogynecol J Pelvic Floor Dysfunct Date: 2006-06-08
Authors: Emily S Lukacz; Jean M Lawrence; J Galen Buckwalter; Raoul J Burchette; Charles W Nager; Karl M Luber Journal: Int Urogynecol J Pelvic Floor Dysfunct Date: 2005-04-26
Authors: Rachel N Pauls; Rebecca G Rogers; Mitesh Parekh; Joan Pitkin; Dorothy Kammerer-Doak; Peter Sand Journal: Int Urogynecol J Date: 2014-11-13 Impact factor: 2.894
Authors: J Eric Jelovsek; Alayne D Markland; William E Whitehead; Matthew D Barber; Diane K Newman; Rebecca G Rogers; Keisha Dyer; Anthony Visco; Vivian W Sung; Gary Sutkin; Susan F Meikle; Marie G Gantz Journal: Contemp Clin Trials Date: 2015-08-18 Impact factor: 2.226
Authors: Cindy L Amundsen; Margaret E Helmuth; Abigail R Smith; John O L DeLancey; Catherine S Bradley; Kathryn E Flynn; Kimberly S Kenton; H Henry Lai; David Cella; James W Griffith; Victor P Andreev; J Eric Jelovsek; Alice B Liu; Ziya Kirkali; Claire C Yang Journal: Neurourol Urodyn Date: 2019-11-25 Impact factor: 2.696
Authors: Charles W Nager; Halina Zyczynski; Rebecca G Rogers; Matthew D Barber; Holly E Richter; Anthony G Visco; Charles R Rardin; Heidi Harvie; Dennis Wallace; Susan F Meikle Journal: Female Pelvic Med Reconstr Surg Date: 2016 Jul-Aug Impact factor: 2.091
Authors: Shunaha Kim-Fine; Danielle D Antosh; Ethan M Balk; Kate V Meriwether; Gregg Kanter; Alexis A Dieter; Mamta M Mamik; Meadow Good; Ruchira Singh; Alexandriah Alas; Mohamed Foda; David D Rahn; Rebecca G Rogers Journal: Int Urogynecol J Date: 2021-05-14 Impact factor: 2.894
Authors: Catherine J Teig; Margreth Grotle; Malcolm J Bond; Cecilia A C Prinsen; Marie A Ellström Engh; Milada S Cvancarova; Møyfrid Kjøllesdal; Angelita Martini Journal: Int Urogynecol J Date: 2017-01-06 Impact factor: 2.894
Authors: Anne P Cameron; Christina Lewicky-Gaupp; Abigail R Smith; Brian T Helfand; John L Gore; J Quentin Clemens; Claire C Yang; Nazema Y Siddiqui; H Henry Lai; James W Griffith; Victor P Andreev; Gang Liu; Kevin Weinfurt; Cindy L Amundsen; Catherine S Bradley; John W Kusek; Ziya Kirkali Journal: J Urol Date: 2017-10-28 Impact factor: 7.450